Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding Niemann-Pick type C disease: a fat problem.

Inez Vincent1, Bitao Bu, Robert P Erickson

  • 1Department of Pathology, K078A, University of Washington, Box 357705, 1959 NE Pacific Avenue, Seattle, WA 98195, USA. ivincent@u.washington.edu

Current Opinion in Neurology
|March 20, 2003
PubMed
Summary

Niemann-Pick type C disease causes neurodegeneration despite lipid reduction in other organs. Brain pathology is independent, highlighting the need for neurological research for effective Niemann-Pick C disease treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HMGB1-mediated endoplasmic reticulum stress in monocyte-derived dendritic cells regulates CD4+ T cell immune responses in myasthenia gravis.

Journal of neuroinflammation·2026
Same author

Eculizumab in Myasthenia Gravis: A Multicenter Retrospective Real-World Study in China.

Neurology and therapy·2026
Same author

Elevated serum TNF-α in patients with immune-mediated necrotizing myopathy correlates with muscle damage.

BMC immunology·2026
Same author

Experience Using Efgartigimod to Treat Juvenile Myasthenia Gravis in China: A Multicenter Retrospective Study.

Muscle & nerve·2026
Same author

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.

Journal of neurology·2026
Same author

Successful Treatment of Multifocal Demyelinating Sensory-Motor Neuropathy (Lewis-Sumner Syndrome) With Rituximab: A Case Report.

The American journal of case reports·2026

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Niemann-Pick type C disease (NPC) is a fatal genetic disorder characterized by progressive neurological deterioration.
  • The exact mechanisms linking lipid homeostasis defects to neurodegeneration in NPC remain unclear.
  • Research has historically focused on extracerebral lipid accumulation, neglecting the central nervous system (CNS) manifestations.

Purpose of the Study:

  • To consolidate current knowledge on brain lipid metabolism and neuropathology in Niemann-Pick type C disease.
  • To provide an updated overview of the CNS disease in NPC.
  • To identify promising avenues for future research into NPC neuropathology.

Main Methods:

  • Review of recent findings on Niemann-Pick type C disease neurological features.

Related Experiment Videos

  • Analysis of studies investigating lipid metabolism and neuropathology in NPC models.
  • Synthesis of research on brain-autonomous pathology in NPC.

    • Main Results:

    • Strategies reducing lipid overload are ineffective in preventing neurodegeneration in NPC.
    • The central nervous system disease in NPC is brain-autonomous, independent of visceral pathology.
    • Studies in NPC gene-1-deficient mice reveal novel therapeutic targets for neurodegeneration.

    Conclusions:

    • The brain pathology in Niemann-Pick type C disease is independent of extracerebral complications, impacting treatment strategies.
    • Further research into the neurological mechanisms of NPC is crucial for improved clinical diagnosis and patient management.